BAL Germany H1 EBIT loss widens to EUR 60,000; H1 revenue falls 4.59% to EUR 187,000
Reuters2026/08/27 08:47- BAL Germany posted a first-half 2026 operating loss (EBIT) of EUR 60,000, widening from EUR 26,000 a year earlier.
- EBITDA swung to a loss of EUR 29,200 from a profit of EUR 4,200 in the prior-year period.
- Net loss deepened to EUR 73,100, while revenue slipped to EUR 187,000.
- Rental and leasing income fell 8.2% to EUR 119,300 due to the sale of three residential units; average vacancy rose 2 percentage points to 7%.
- 2026 EBIT outlook cut to a loss of EUR 90,000-EUR 100,000; 2027 seen returning to a profit of EUR 60,000-EUR 70,000.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
